While President Donald Trump’s White House has hinted at new opportunities for states to develop new approaches to their Medicaid prescription drug programs, other states have already begun taking steps on their own.
State officials during a National Academy for State Health Policy pointed to a set of approaches which could, with the federal government’s support, help reverse the drug cost trajectory.
According to a blog post on Health Affairs, Utah, Vermont, West Virginia, Oklahoma and Missouri are working to push legislation aimed at developing cost-saving wholesale drug import programs of some expensive drugs from Canada. The legislation, however, would require approval from the Department of Health and Human Services secretary.
To read more on how states are working on this issue, click here.